Browsing Tag

durvalumab

Theriva Biologics Announces Presentation at the 14th International Oncolytic…

Eli Pacheco Oct 24, 2022 0

ROCKVILLE, Md., Oct. 24, 2022 (GLOBE NEWSWIRE) -- Theriva Biologics (NYSE American: TOVX), (“Theriva” or the “Company”), a diversified clinical-stage company developing therapeutics…

Health

Efficacy of Durvalumab for Early-Stage TNBC Examined by Race

Eli Pacheco Aug 20, 2022 0

Physician’s Briefing Staff FRIDAY, Aug. 19, 2022 (HealthDay News) -- Among patients with early-stage triple-negative breast cancer (TNBC), the…

Health

Durvalumab Combinations Push the Response Envelope in Unresectable NSCLC

Eli Pacheco May 3, 2022 0

Patients with unresectable stage III non-small cell lung cancer (NSCLC) had a higher response…

Health

New Developments in Triple-Negative Breast Cancer Therapies

Eli Pacheco Jul 8, 2021 0

The recent virtual American Society of Clinical Oncology (ASCO) annual meeting featured several breast…

Health

Preoperative Anti-PD-L1 Effective in Triple-Negative Breast Cancer

Eli Pacheco Jun 24, 2021 0

Patients with early triple-negative breast cancer had improved outcomes with the addition of durvalumab…

Health

No Boost in pCR With Added Atezolizumab in HER2-Positive Early Breast Cancer

Eli Pacheco Jun 22, 2021 0

Adding atezolizumab (Tecentriq) to standard of care treatment for patients with high-risk,…